Cannabis Public Companies Set to Supply Denmark With Cannabis | CashCropToday
0 Shares 258 Views

Cannabis Public Companies Set to Supply Denmark With Cannabis

February 23, 2018
258 Views

Aurora Cannabis (TSX: ACB) and Denmark tomato producer Alfred Pedersen & Son have plans set in place to construct a 93,000 sq. ft. cultivation facility located in Odense.

Aurora and Alfred Pedersen & Son have recently entered into a joint venture, under the name Aurora Nordic Cannabis, which plants to product 120,000 kg of cannabis a year.

Aurora Nordic Cannabis had to go through a strict approval process to cultivate cannabis in Denmark. It required receiving approval from the Laegemiddelstyrelsen, a  Danish medical agency, the Landbrugsstyrelsen, an agricultural agency, and the national police, Rigspolitiet. The company already has ambitious plans to expand its operations to the countries of Norway and Sweden.

Actually Aurora Cannabis isn’t the only company setting up operations in Denmark. The company’s rival Canopy Growth Corp has constructed their own 40,000 sq. ft. facility with partner Spectrum Cannabis Denmark in Odense.

 

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
269 views
Market Watch
269 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
192 views
Global
192 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
189 views
Manufacturing
189 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: